Saturday, February 07, 2026 | 11:39 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Natco Pharma Share Price

Know More
BSENSE

823.25-6.55 (-0.79%)

6-Feb-2026

823.55-5.40 (-0.65%)

6-Feb-2026

BSE : 524816

NSE : NATCOPHARM

Sector : Health care

ISIN Code : INE987B01026

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 06-Feb-2026

Market Cap (₹ Cr)

14,744

Traded Value (₹ Cr)

3.16

Volume (Shares)

38,445

Face Value (₹)

2

52-Week High (₹)

-

52-Week High Date

-

52-Week Low (₹)

-

52-Week Low Date

-

All Time High (₹)

-

All Time High Date

-

All Time Low (₹)

-

All Time Low Date

-

Natco Pharma Ltd

Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company as 'Natco Fine Pharmaceuticals Private Limited'. The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation dated 30 December 1994 issued by the RoC Andhra Pradesh. Natco Pharma is a vertically integrated and R&...
Read More

Natco Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

14,750

EPS - TTM (₹) [C]

85.79

P/E Ratio (X) [C]

9.60

Face Value (₹) 2
Latest Dividend (%)75.00
Latest Dividend Date 20-Nov-2025
Dividend Yield (%) 0.73
Book Value Share (₹) [C]482.93
P/B Ratio (₹) [C]1.71

Funds Owning this Stock

Load more

Research Reports

DateBrokerActionPrices(₹) Report
24-Jul-2025Edelweiss Securities Hold 1,110
04-Oct-2024Edelweiss Securities Hold 1,440

Stock Strength

Today's Low/High (₹)

812.30

827.95

Week Low/High (₹)

806.05

881.00

Month Low/High (₹)

806.05

960.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-1.42%29.72%1.59%1.47%
1 Month-11.08%17.11%-1.74%-1.85%
3 Month0.41%32.26%0.15%0.38%
6 Month-10.26%18.13%3.77%4.56%
1 Year-37.96%-18.35%7.07%8.86%
3 Year55.62%104.93%38.13%44.63%

Company Info

Company Information

Chairman / Executive Director / M D / Promoter : V C Nannapaneni

Vice Chairman & CEO : Rajeev Nannapaneni

ED / EVP : PSRK Prasad

ED / President : D Linga Rao

Independent Non Exe. Director : A D Murthy Chavali

Independent Non Exe. Director : Vijayabhaskar Dronadula

Independent Non Exe. Director : B. Lakshminarayana

Independent Non Exe. Director : Kantipudi Suma

Independent Non Exe. Director : Nitin Jain

Company Sec. & Compli. Officer : Chekuri Venkat Ramesh

Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532

Email:investors@natcopharma.co.in

URL:http://www.natcopharma.co.in

FAQs about Natco Pharma Ltd

1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 823.25 at close on 6th Feb 2026. Natco Pharma Ltd share price was down by 0.79% from the previous closing price of Rs 829.80. Natco Pharma Ltd share price trend:

  • Last 1 Month: Natco Pharma Ltd share price moved down by 11.08% on BSE.
  • Last 3 Months: Natco Pharma Ltd share price moved up by 0.41% on BSE.
  • Last 12 Months: Natco Pharma Ltd share price moved down by 37.96% on BSE.
  • Last 3 Years: Natco Pharma Ltd share price moved up by 55.62% on BSE.


2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 9.60
  • Price to book value ratio is 1.71
  • Dividend yield of 0.73
  • The EPS (trailing 12 months) of the Natco Pharma Ltd stock is Rs 85.79


3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 14,744 crore.


5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 517.90 crore on a total income of Rs 1,463.00 crore for the quarter ended 2025.


6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Acutaas Chemical, Alembic Pharma, Jubilant Pharmo, Natco Pharma, Concord Biotech, Caplin Point Lab, Granules India.


7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows:

  • Promoter holding in Natco Pharma Ltd has gone down to 49.48 per cent as of Dec 2025 from 49.56 per cent as of Mar 2025.